Sysmex, a $2.7 billion Japanese maker of blood testing machines, is in the cross-hairs of Sight Diagnostics, an Israeli company that announced December 4 that it had received FDA clearance for its competing product, OLO, according to Reuters. The US FDA 510(k) clearance will enable Sight to sell its OLO analyzer to laboratories run by diagnostic providers and hospitals.

Read more here.